Published in Front Pharmacol on February 02, 2017
Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science (1998) 17.91
A gene expression database for the molecular pharmacology of cancer. Nat Genet (2000) 13.31
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res (1988) 9.96
Bioavailability of curcumin: problems and promises. Mol Pharm (2007) 8.72
p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res (1995) 6.66
The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J Biol Chem (1997) 4.03
Pharmacology of Curcuma longa. Planta Med (1991) 3.59
Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A (2005) 3.30
Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci U S A (2007) 2.71
Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A (2008) 2.50
The Haber-Weiss reaction and mechanisms of toxicity. Toxicology (2000) 2.30
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann Oncol (2008) 2.27
Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr (1999) 1.97
Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J (1999) 1.94
Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med (2009) 1.94
Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta (2012) 1.89
Ascorbic acid and cancer: a review. Cancer Res (1979) 1.88
CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer. Cell (2015) 1.77
Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nat Commun (2014) 1.75
Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing. Int J Mol Sci (2009) 1.67
Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res (2001) 1.63
Repellency of volatile oils from plants against three mosquito vectors. J Vector Ecol (2001) 1.62
Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol (1993) 1.58
Ferula asa-foetida and Curcuma longa in traditional medical treatment and diet in Nepal. J Ethnopharmacol (1999) 1.53
Curcumin therapy in inflammatory bowel disease: a pilot study. Dig Dis Sci (2005) 1.46
Combined ascorbic acid and sodium nitrite treatment induces oxidative DNA damage-associated mutagenicity in vitro, but lacks initiation activity in rat forestomach epithelium. Toxicol Sci (2008) 1.40
Targeting PDK1 in cancer. Curr Med Chem (2011) 1.38
Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem (2004) 1.37
Is resistance useless? Multidrug resistance and collateral sensitivity. Trends Pharmacol Sci (2009) 1.37
Ascorbic acid and carnitine biosynthesis. Am J Clin Nutr (1991) 1.36
Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. Antioxid Redox Signal (2011) 1.34
Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects. Free Radic Biol Med (2009) 1.31
Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem (1997) 1.22
Frequent truncating mutation of TFAM induces mitochondrial DNA depletion and apoptotic resistance in microsatellite-unstable colorectal cancer. Cancer Res (2011) 1.20
Free radical scavenging activity and characterization of sesquiterpenoids in four species of Curcuma using a TLC bioautography assay and GC-MS analysis. Molecules (2010) 1.18
Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1. Cancer Res (2004) 1.18
Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integr Cancer Ther (2005) 1.15
Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation. J Cell Physiol (2006) 1.14
Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer (1996) 1.14
High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion. Oncotarget (2013) 1.14
Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage. Mol Cancer Ther (2009) 1.12
Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics (2016) 1.11
Effect of high-dose intravenous vitamin C on inflammation in cancer patients. J Transl Med (2012) 1.09
Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells. Cancer Res (1990) 1.08
Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs. Biol Pharm Bull (2003) 1.07
Curcumin ameliorates ethanol and nonethanol experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol (2003) 1.06
Mechanisms of ascorbic acid stimulation of norepinephrine synthesis in neuronal cells. Biochem Biophys Res Commun (2012) 1.06
The role of vitamins in cancer: a review. Nutr Cancer (2011) 1.05
Aldehyde dehydrogenase 3B1 (ALDH3B1): immunohistochemical tissue distribution and cellular-specific localization in normal and cancerous human tissues. J Histochem Cytochem (2010) 1.01
Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. Biochem Pharmacol (1998) 1.00
High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis. J Transl Med (2009) 1.00
Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics. Antioxid Redox Signal (2013) 0.97
Presence of an acidic glycoprotein in the serum of arthritic rats: modulation by capsaicin and curcumin. Mol Cell Biochem (1997) 0.97
Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. Am J Respir Cell Mol Biol (2004) 0.95
Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion. Oncology (1998) 0.94
Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin. Phytomedicine (2011) 0.94
Enhanced antitumor activity of vitamin C via p53 in cancer cells. Free Radic Biol Med (2012) 0.91
Expression and functional pathway analysis of nuclear receptor NR2F2 in ovarian cancer. J Clin Endocrinol Metab (2013) 0.91
Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review. Oncologist (2015) 0.90
Anti-apoptotic effects of curcumin on photosensitized human epidermal carcinoma A431 cells. J Cell Biochem (2004) 0.89
Change in gene expression subsequent to induction of Pnn/DRS/memA: increase in p21(cip1/waf1). Oncogene (2001) 0.88
Curcumin AntiCancer Studies in Pancreatic Cancer. Nutrients (2016) 0.87
Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL mice. Biochem Pharmacol (2005) 0.87
Ascorbic acid as a chemotherapeutic agent. Arch Pediatr (1952) 0.86
Membrane-type matrix metalloproteinases mediate curcumin-induced cell migration in non-tumorigenic colon epithelial cells differing in Apc genotype. Carcinogenesis (2002) 0.86
c-Jun N-terminal kinase is involved in motility of endothelial cell. Exp Mol Med (2001) 0.86
Activity of a combination of three cinchona bark alkaloids against Plasmodium falciparum in vitro. Antimicrob Agents Chemother (1988) 0.86
Inhibition of nuclear factor-kappa B prevents staphylococcal enterotoxin A-induced fever. Mol Cell Biochem (2004) 0.85
The treatment of poliomyelitis and other virus diseases with vitamin C. South Med Surg (1949) 0.85
Catalytic therapy of cancer with ascorbate and extracts of medicinal herbs. Evid Based Complement Alternat Med (2007) 0.85
Molecular mechanisms of pharmacological doses of ascorbate on cancer cells. Wien Med Wochenschr (2015) 0.84
Ancient Chinese methods are remarkably effective for the preparation of artemisinin-rich extracts of Qing Hao with potent antimalarial activity. Molecules (2010) 0.84
Curcumin: a potent inhibitor of leukotriene B4 formation in rat peritoneal polymorphonuclear neutrophils (PMNL) Planta Med (1992) 0.84
Molecular targets of curcumin for cancer therapy: an updated review. Tumour Biol (2016) 0.84
Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat. Mol Cell Biochem (1995) 0.83
Pathologic alterations detected in acute pancreatitis induced by sodium taurocholate in rats and therapeutic effects of curcumin, ciprofloxacin and metronidazole combination. Pancreatology (2005) 0.83
Stereoelectronic features of the cinchona alkaloids determine their differential antimalarial activity. Bioorg Med Chem (1999) 0.83
A systematic approach to identify novel cancer drug targets using machine learning, inhibitor design and high-throughput screening. Genome Med (2014) 0.82
Studies on the role of some synthetic curcuminoid derivatives in the inhibition of tumour specific angiogenesis. J Exp Clin Cancer Res (2003) 0.82
Attenuated expression of DFFB is a hallmark of oligodendrogliomas with 1p-allelic loss. Mol Cancer (2005) 0.81
The crystal structure of human WD40 repeat-containing peptidylprolyl isomerase (PPWD1). FEBS J (2008) 0.81
[Effect of turmeric volatile oil on the respiratory tract]. Zhongguo Zhong Yao Za Zhi (1998) 0.81
Blocking NF-kappaB activation may be an effective strategy in the fever therapy. Jpn J Physiol (2003) 0.80
Factors determining sensitivity or resistance of tumor cell lines towards artesunate. Chem Biol Interact (2010) 0.80
Curcuma longa (turmeric). Monograph. Altern Med Rev (2001) 0.80
[The effect of chelidonium- and turmeric root extract on upper abdominal pain due to functional disorders of the biliary system. Results from a placebo-controlled double-blind study]. Med Klin (Munich) (1999) 0.80
Pharmacogenomic determination of genes associated with sensitivity or resistance of tumor cells to curcumin and curcumin derivatives. J Nutr Biochem (2011) 0.79
Effects of sesamin and curcumin on delta 5-desaturation and chain elongation of polyunsaturated fatty acid metabolism in primary cultured rat hepatocytes. J Nutr Sci Vitaminol (Tokyo) (1992) 0.79
Inhibition of neutrophil response by curcumin. Agents Actions (1989) 0.79
Testing of lipoxygenase inhibitors, cyclooxygenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis. Skin Pharmacol (1994) 0.78
Curcumin inhibits protease-activated receptor-2 and -4-mediated mast cell activation. Clin Chim Acta (2003) 0.78
Curcumin reduces the expression of survivin, leading to enhancement of arsenic trioxide-induced apoptosis in myelodysplastic syndrome and leukemia stem-like cells. Oncol Rep (2016) 0.76
A novel double carbonyl analog of curcumin induces the apoptosis of human lung cancer H460 cells via the activation of the endoplasmic reticulum stress signaling pathway. Oncol Rep (2016) 0.76
Turmeric, haldi or haridra, in eye disease. Antiseptic (1950) 0.76
Anticancer potential of dietary vitamin D and ascorbic acid: A review. Crit Rev Food Sci Nutr (2017) 0.76
Mechanism of Ascorbate-Induced Cell Death in Human Pancreatic Cancer Cells: Role of Bcl-2, Beclin 1 and Autophagy. Planta Med (2015) 0.76
p53 modulates the activity of the GLI1 oncogene through interactions with the shared coactivator TAF9. DNA Repair (Amst) (2015) 0.76
Anti-Proliferative and Apoptosis-Inducing Effect of Theabrownin against Non-small Cell Lung Adenocarcinoma A549 Cells. Front Pharmacol (2016) 0.76
The Combined Effects of Ethylene and MeJA on Metabolic Profiling of Phenolic Compounds in Catharanthus roseus Revealed by Metabolomics Analysis. Front Physiol (2016) 0.75
Both Phenolic and Non-phenolic Green Tea Fractions Inhibit Migration of Cancer Cells. Front Pharmacol (2016) 0.75
Drug Repurposing of the Anthelmintic Niclosamide to Treat Multidrug-Resistant Leukemia. Front Pharmacol (2017) 0.75